Natalizumab : Sécurité et Efficacité à 15 Ans (Étude TOP)

from La biblio Neuro · host Dr Nicolas Landragin

Cette source détaille les conclusions finales du Tysabri Observational Program (TOP), une étude internationale de grande ampleur ayant suivi plus de 6 000 patients sur une période de 15 ans.Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Greco A, et al. Tysabri Observational Program (TOP): long-term safety and effectiveness of natalizumab treatment in relapsing-remitting multiple sclerosis over 15 years. J Neurol Neurosurg Psychiatry. 2026Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Episode metadata supplied by the publisher feed · Published May 19, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Natalizumab : Sécurité et Efficacité à 15 Ans (Étude TOP)

0:00 5:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of La biblio Neuro?

This episode is 5 minutes long.

When was this La biblio Neuro episode published?

This episode was published on May 19, 2026.

Can I download this La biblio Neuro episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!